VRNA - Verona Pharma plc
106.91
0.120 0.112%
Share volume: 1,871,959
Last Updated: 10-06-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$106.79
0.12
0.00%
Summary score
41%
Profitability
35%
Dept financing
32%
Liquidity
75%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Jun-2021 - 30-Jun-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-1.14%
Return on sales
-16.89%
Return on invested capital
0%
Total debt ratio
55.07%
Debt ratio change over timeo
0%
Current Ratio
10.07%
Quick Ratio
9.92%
Cash Position Ratio
8.34%
Short-term ratios 30-Jun-2024 - 30-Jun-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-1.14%
Return on sales
-16.89%
Return on invested capital
0%
Total debt ratio
55.07%
Debt ratio change over timeo
0%
Current Ratio
10.07%
Quick Ratio
9.92%
Cash Position Ratio
8.34%
Last quarter ratios 30-Jun-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
2.51%
Return on sales
12.9%
Return on invested capital
0%
Total debt ratio
51.42%
Debt ratio change over time
0%
Current Ratio
10.71%
Quick Ratio
10.54%
Cash Position Ratio
8.55%
Performance ratios (change over 4 years) 30-Jun-2021 - 30-Jun-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | VRNA | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 13.37% | 9.26% | 24.74% |
| Return on assets | -1.14% | 4.46% | 3.19% | 1.96% |
| Return on sales | -16.89% | 29.32% | 25.1% | 26.16% |
| Return on invested capital | 0% | 8.27% | 9.6% | 4.15% |
| Profitability | 0% | 85% | 74% | 69% |
| Total debt ratio | 55.07% | 80.99% | 59.51% | 92.59% |
| Debt ratio change over time | 0% | -13.82% | -64.56% | 51.48% |
| Dept financing | 15% | 22% | 16% | 50% |
| Current Ratio | 10.07% | 1.27% | 1.1% | 0.7% |
| Quick Ratio | 9.92% | 0.98% | 0.86% | 0.59% |
| Cash Position Ratio | 8.34% | 0.11% | 0.47% | 0.15% |
| Liquididy | 75% | 6% | 7% | 5% |
| Short-term ratios | VRNA | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -1.14% | 4.77% | 3.56% | 0.99% |
| Return on sales | -16.89% | 31.14% | 23.64% | 19.08% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 38% | 21% |
| Total debt ratio | 55.07% | 81.85% | 60.01% | 98.11% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 39% | 21% | 15% | 25% |
| Current Ratio | 10.07% | 1.27% | 1.1% | 0.7% |
| Quick Ratio | 9.92% | 0.98% | 0.86% | 0.59% |
| Cash Position Ratio | 8.34% | 0.11% | 0.47% | 0.15% |
| Liquididy | 75% | 6% | 6% | 4% |